Spitz, I M <br/><br/>
Long-acting gonadotropin-releasing hormone implant to maintain medical castration for two years in men with prostate cancer.  [electronic resource] 

 -  The New England journal of medicine  May 1999 
 - 1439 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>0028-4793 
<br/><br/><label>Standard No.: </label>10.1056/NEJM199905063401814  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Androgen Antagonists--therapeutic use<br/>Cyproterone Acetate--therapeutic use<br/>Drug Implants<br/>Drug Therapy, Combination<br/>Flutamide--therapeutic use<br/>Gonadotropin-Releasing Hormone--administration & dosage<br/>Humans<br/>Luteinizing Hormone--blood<br/>Male<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms--blood<br/>Testosterone--blood